Logo image
Back
Increased 30-Day Mortality Risk in Patients With Diabetes Mellitus After Colon Cancer Surgery: A Mediation Analysis
Journal article   Open access   Peer reviewed

Increased 30-Day Mortality Risk in Patients With Diabetes Mellitus After Colon Cancer Surgery: A Mediation Analysis

Mario Schootman, Donna B. Jeffe, Kendra L. Ratnapradipa, Jan M. Eberth and Nicholas O. Davidson
Diseases of the colon & rectum, v 63(3), pp 290-299
Mar 2020
DOI: https://doi.org/10.1097/DCR.0000000000001586
PMID: 31977584
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://europepmc.org/articles/pmc8573828?pdf=renderView
Accepted (AM)Open Access (License Unspecified),  Open

Abstract

Gastroenterology & Hepatology Life Sciences & Biomedicine Science & Technology Surgery
BACKGROUND: Patients with (versus without) diabetes mellitus who develop colon cancer are at increased risk of dying within 30 days after surgery. OBJECTIVE: The purpose of this study was to identify potential mediators of the effect of diabetes mellitus on all-cause 30-day mortality risk after surgery for colon cancer. DESIGN: A retrospective cohort study was conducted using the 2013-2015 National Surgical Quality Improvement Program data. SETTING: The study was conducted at various hospitals across the United States (from 435 to 603 hospitals). PATIENTS: Patients who underwent resection for colon cancer with or without obstruction based on the National Surgical Quality Improvement Program colectomy module were included. Patients who had ASA physical status classification V or metastatic disease and those who presented emergently were excluded. Patients were classified as "no diabetes," "diabetes not requiring insulin," or "diabetes requiring insulin." Potential reasons for increased risk of dying within 30 days were treatment related, comorbidity, health behaviors, surgical complications, and biomarkers of underlying disease. MAIN OUTCOME MEASURES: We measured all-cause 30-day mortality. RESULTS: Of 26,060 patients, 18.8% (n = 4905) had diabetes mellitus that was treated with insulin (n = 1595) or other antidiabetic agents (n = 3340). Patients with diabetes mellitus had a 1.57 (95% CI, 1.23-1.99) higher unadjusted odds of dying within 30 days versus patients without diabetes mellitus. In the multivariable model, 76.7% of the association between diabetes mellitus and 30-day mortality was explained; patients with diabetes mellitus were equally likely to die within 30 days versus those without diabetes mellitus (OR = 1.05 (95% CI, 0.81-1.35)). Anemia and sepsis explained 33.7% and 15.2% of the effect of diabetes mellitus on 30-day mortality (each p < 0.0001). Treatment-related variables, cardiovascular disease, surgical complications, and biomarkers played limited roles as mediators. LIMITATIONS: The study was limited to larger hospitals, and limited information about duration and type of diabetes mellitus was available. CONCLUSIONS: Better management and prevention of anemia and sepsis among patients with diabetes mellitus may reduce their increased risk of death after colon cancer resection.

Metrics

6 Record Views
12 citations in Web of Science
10 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Gastroenterology & Hepatology
Surgery
Logo image